NAD+ and Longevity: What We Know About Oral, Injectable and IV Options

NAD+ Has Become a Longevity Buzzword. How Much Is Actually Proven?

NAD+ has moved quickly from the laboratory into supplements, longevity clinics, IV lounges, and conversations about biological aging.

You may see oral NAD+ boosters marketed for cellular energy. Injectable NAD+ may be promoted for recovery or mental clarity. IV NAD+ infusions are sometimes positioned as a more direct way to support mitochondrial function and healthy aging.

The biology behind NAD+ is genuinely interesting.

The clinical evidence is more complicated.

Nicotinamide adenine dinucleotide, or NAD+, is an essential molecule involved in energy metabolism, DNA repair, cellular stress responses, and many other processes necessary for normal human function.

NAD+ metabolism also changes with age, which has led researchers to ask an important question:

Could maintaining or increasing NAD+ help humans stay healthier as they get older?

So far, human studies show that certain oral NAD+ precursors can reliably alter NAD-related biomarkers. What researchers have not established is that NAD+ supplementation meaningfully extends human lifespan.

And when comparing oral supplements with injectable or IV NAD+, the amount and quality of evidence are very different.

Here is what we currently know.

What Is NAD+?

NAD+ is a coenzyme found in virtually every cell of the body.

It plays a major role in converting nutrients into usable cellular energy.

NAD+ also participates in reactions involving several important enzyme systems, including:

• Sirtuins
• PARP enzymes involved in DNA repair
• CD38 and other NAD-consuming enzymes
• Mitochondrial energy metabolism
• Cellular responses to oxidative and metabolic stress

One of NAD+’s most fundamental jobs involves transferring electrons during metabolic reactions.

NAD+ accepts electrons and becomes NADH. NADH can then participate in reactions involved in producing ATP, the molecule cells use as an immediate source of energy.

This explains why NAD+ is frequently described as being connected to cellular energy and mitochondrial function.

But that does not mean increasing NAD+ automatically produces more energy, reverses aging, or improves symptoms.

Human physiology is rarely that simple.

Does NAD+ Decline With Age?

Research suggests that NAD+ metabolism can become altered with aging.

Several factors may contribute, including:

• Changes in NAD+ synthesis
• Increased activity of NAD-consuming enzymes
• Chronic inflammation
• Oxidative stress
• Metabolic dysfunction
• DNA damage
• Changes in mitochondrial function

These observations have generated substantial interest in strategies designed to increase NAD+ availability.

Animal research has been especially encouraging.

In mice and other experimental models, increasing NAD+ availability has sometimes improved metabolic health, mitochondrial function, inflammation, physical performance, and other age-related outcomes.

The challenge is translating those findings to people.

A 2026 systematic review examining human and animal research found that oral NAD+ precursors such as nicotinamide riboside and nicotinamide mononucleotide consistently affect NAD-related biomarkers in humans. However, improvements in functional, metabolic, cardiovascular, and other clinically relevant outcomes remain inconsistent.

In other words:

Increasing an NAD+ biomarker is not the same thing as proving that someone will live longer or remain healthier longer.

The Different Ways People Try to Increase NAD+

The term “NAD+ therapy” can describe several very different approaches.

The most common include:

1. Oral NAD+ precursors such as nicotinamide riboside (NR)
2. Oral nicotinamide mononucleotide (NMN)
3. Direct oral NAD+ formulations
4. Subcutaneous or intramuscular injections
5. Intravenous NAD+ infusions

These approaches should not be considered interchangeable.

Their absorption, metabolism, cost, convenience, safety considerations, and research support differ substantially.

Oral NAD+ Supplements: What Does the Evidence Show?

Most clinical research has not involved swallowing NAD+ itself.

Instead, researchers have studied NAD+ precursors, molecules the body can use to produce NAD+.

Two of the best-known are:

Nicotinamide Riboside (NR)

NR is a form of vitamin B3 that can enter NAD+ synthesis pathways.

Multiple human trials have shown that oral NR can increase blood concentrations of NAD+ and related metabolites.

For example, an eight-week randomized controlled trial found that oral NR increased whole-blood NAD+ in a dose-dependent manner. Participants receiving 1,000 mg per day experienced substantially greater increases than those receiving lower doses.

That is strong evidence of biological target engagement.

But what happens after NAD+ increases?

That is less certain.

Studies have investigated NR for:

• Blood pressure
• Metabolic function
• Exercise response
• Cognitive function
• Muscle recovery
• Inflammation
• Mitochondrial health

Results have been mixed.

Some studies show changes in specific biomarkers or subgroups. Others find little meaningful difference in clinical outcomes.

For example, clinical research in older adults with mild cognitive impairment has confirmed that NR can increase NAD-related biomarkers, but evidence that this translates into major cognitive improvement remains limited.

This distinction matters when interpreting supplement advertising.

NR can increase NAD+.

We do not yet know that increasing NAD+ with NR meaningfully slows human aging.

Those are two different claims.

What About NMN?

Nicotinamide mononucleotide, or NMN, is another precursor involved in NAD+ synthesis.

Human NMN research has expanded considerably over the past several years.

Trials have evaluated NMN doses ranging from several hundred milligrams to considerably higher doses over relatively short periods.

One notable randomized trial studied postmenopausal women with prediabetes who were overweight or obese.

After 10 weeks, NMN supplementation improved skeletal-muscle insulin sensitivity and insulin signaling compared with placebo.

Other studies have demonstrated that oral NMN can alter circulating NAD-related metabolites.

However, those findings do not mean NMN has been shown to prevent aging.

A 2026 systematic review and meta-analysis of 15 NMN trials found that short-term supplementation appeared generally well tolerated, but researchers did not find clear improvements in outcomes including body weight, BMI, fasting glucose, HbA1c, lipid levels, or systolic blood pressure across the available studies.

The overall pattern is similar to NR:

NMN clearly interacts with NAD+ biology, but its long-term impact on health span and lifespan remains uncertain.

Does Oral NAD+ Itself Work?

Traditionally, researchers have focused on NR and NMN because NAD+ is a relatively large molecule and its absorption and cellular uptake are more complicated.

New oral NAD+ formulations are now being investigated.

A small randomized Phase 0/1b study published in 2026, for example, examined a modified oral NAD+ formulation in adults ages 45 to 75 and reported changes in intracellular NAD-related measures after several days.

This is interesting early-stage research.

It does not yet establish that direct oral NAD+ produces superior clinical outcomes compared with NR, NMN, or other approaches.

When evaluating any NAD+ product, it is useful to ask:

Does the study show that the product changes NAD+ levels, or does it show that people actually become healthier?

Those are very different standards of evidence.

Injectable NAD+: Is It Better Than Oral Supplements?

Another increasingly popular approach involves administering NAD+ or an NAD+ precursor through injections.

These may include:

• Subcutaneous injections
• Intramuscular injections
• IV push administration
• Traditional IV infusions

The argument usually sounds straightforward:

If swallowing a compound involves digestion and metabolism, why not bypass the gastrointestinal system and inject it directly?

Biologically, that question is reasonable.

Clinically, however, there is still very limited evidence showing that injectable NAD+ produces superior longevity outcomes.

A major 2026 systematic review found no qualifying human outcomes trials demonstrating that intravenous or intramuscular NAD+ itself improves anti-aging or wellness outcomes.

Research into injectable NAD-related compounds is now underway.

For example, registered clinical trials are investigating subcutaneous and intramuscular nicotinamide riboside injections and comparing different injectable routes with NAD+.

That is important progress.

It also tells us something about the current state of the field:

Researchers are still working out fundamental questions about injectable dosing, absorption, tolerability, and biological effects.

The evidence base is not yet mature enough to conclude that injections provide better longevity outcomes than oral precursors.

What About IV NAD+ Therapy?

IV NAD+ has become particularly popular in wellness and longevity settings.

A typical infusion delivers NAD+ directly into the bloodstream over a prolonged period.

Supporters may claim IV NAD+ can improve:

• Energy
• Mental clarity
• Recovery
• Fatigue
• Mitochondrial function
• Metabolic health
• Healthy aging

Some people report feeling different after infusions.

But subjective improvement and proven longevity benefits are not the same thing.

What Human Studies Have Found About IV NAD+

One early human study examined NAD+ metabolism during a six-hour IV infusion.

Researchers observed changes in NAD-related metabolites and reported no major adverse events in the small study population.

That study was primarily useful for understanding metabolism and short-term exposure.

It was not designed to prove that IV NAD+ slows aging.

More recently, a 2026 retrospective pilot study compared four days of IV NAD+ with intravenous NR in a commercial wellness setting.

Only 14 participants were included.

People receiving NAD+ frequently experienced gastrointestinal symptoms, increased heart rate, and chest pressure during administration. Infusions had to be delivered more slowly, averaging approximately 97 minutes compared with 37 minutes for IV NR.

The study found no major short-term changes in several liver, kidney, thyroid, or inflammatory markers.

However, it was:

• Very small
• Retrospective
• Conducted in a commercial setting
• Short in duration
• Not designed to measure longevity

Several study authors were also employed by the wellness company involved, which should be considered when interpreting the results.

The study is useful preliminary evidence.

It is not proof of an anti-aging effect.

Does IV NAD+ Work Better Because It Goes Directly Into the Bloodstream?

This is one of the most common assumptions surrounding IV therapy.

But higher or faster exposure does not automatically equal better health outcomes.

The body tightly regulates NAD+ metabolism.

NAD+, NADH, NR, NMN, nicotinamide, and other metabolites move through interconnected biochemical pathways.

The important question is therefore not simply:

“How much NAD+ entered the bloodstream?”

The better question is:

“Did the intervention improve a meaningful clinical outcome?”

Examples would include:

• Better physical function
• Improved metabolic health
• Reduced cardiovascular events
• Reduced frailty
• Improved cognitive function
• Lower disease risk
• Longer healthspan
• Longer lifespan

We currently do not have convincing long-term randomized trials showing that IV NAD+ accomplishes these outcomes in healthy adults.

Oral vs Injectable vs IV NAD+: How Do They Compare?

Option	Human Evidence	Convenience	Main Limitation
Oral NR	Multiple human randomized trials	High	Clinical benefits remain inconsistent
Oral NMN	Growing number of human trials	High	Long-term outcome data are limited
Direct oral NAD+	Emerging research	High	Much less established than NR/NMN
Subcutaneous/IM NAD+ or NR	Early and ongoing research	Moderate	Limited comparative outcomes data
IV NAD+	Small human studies	Low	No established longevity benefit, higher complexity and cost

For someone evaluating NAD+ strictly from an evidence perspective, oral NAD+ precursors currently have the largest body of human clinical research.

That does not make them proven anti-aging therapies.

It simply means researchers know more about them.

Are NAD+ Injections and IVs FDA Approved for Longevity?

This is another important distinction.

Compounded NAD+ products are not FDA-approved medications for extending lifespan, reversing aging, or improving longevity.

FDA explains that compounded drugs are not reviewed before marketing in the same way FDA-approved medications are reviewed for safety, effectiveness, and manufacturing quality.

This does not mean that all compounded medications are inherently inappropriate.

Compounding can serve legitimate medical needs.

But sterile injectable products create additional quality-control considerations.

FDA Has Raised Safety Concerns About Some Compounded NAD+ Injectables

FDA has specifically warned compounders about the use of unsuitable ingredients in sterile NAD+ products.

The agency reported becoming aware of food-grade NAD+ being used to prepare intravenous products and warned that such ingredients may introduce microbial or endotoxin contamination.

FDA has received reports following injectable NAD+ involving symptoms including:

• Severe chills
• Shaking
• Vomiting
• Fatigue

Some patients required medical treatment.

In a January 2026 warning letter involving one compounding facility, FDA documented a NAD+ product containing excessive bacterial endotoxins after several patients developed symptoms including low blood pressure, uncontrollable shaking, shivering, and body aches.

These incidents do not prove that the NAD+ molecule itself caused the reactions.

They highlight why sterility, sourcing, compounding practices, and quality control matter enormously when a substance is injected directly into the body.

Are There Side Effects From NAD+ Therapy?

Possible effects depend on the compound, dose, formulation, and delivery method.

Oral NR or NMN

Short-term clinical studies generally suggest reasonable tolerability.

Reported symptoms may include:

• Gastrointestinal discomfort
• Nausea
• Headache
• Fatigue
• Changes in bowel habits

Available trials remain relatively short compared with the decades over which a longevity intervention would theoretically be used.

Long-term safety therefore needs further study.

Injectable NAD+

Potential concerns include:

• Injection-site pain
• Infection
• Sterility problems
• Dosing errors
• Product-quality variation

IV NAD+

Reported infusion-related symptoms can include:

• Nausea
• Abdominal discomfort
• Chest pressure
• Increased heart rate
• Headache
• Flushing
• Lightheadedness

Infusion speed may influence tolerability.

Any IV therapy also introduces risks associated with venous access, including infection and irritation.

What About NAD+ and Cancer?

This topic requires nuance.

NAD+ is necessary for normal DNA repair, mitochondrial metabolism, and cellular survival.

Those functions are valuable in healthy cells.

Cancer cells also rely on metabolic pathways involving NAD+.

That has led researchers to investigate NAD metabolism from two directions:

• Increasing NAD+ to support healthy aging and cellular resilience
• Inhibiting certain NAD-related pathways as potential cancer treatments

At this point, it would be inappropriate to conclude that standard NAD+ supplementation causes cancer.

It would be equally inappropriate to assume that aggressively increasing NAD+ is universally beneficial for everyone.

People with active cancer, a history of cancer, or other complex medical conditions should discuss NAD-related therapies with their treating clinicians rather than assuming that a general longevity protocol applies to them.

Can NAD+ Actually Extend Human Lifespan?

This is the question that matters most.

At present:

We do not have evidence that oral, injectable, or IV NAD+ therapy extends human lifespan.

Animal studies have provided important mechanistic clues.

Human studies have demonstrated that we can manipulate aspects of NAD+ metabolism.

But no clinical trial has yet shown that taking NR, NMN, injectable NAD+, or IV NAD+ allows people to live meaningfully longer.

That does not mean the research has failed.

It means NAD+ belongs in the category of promising but still investigational longevity science.

NAD+ Biomarkers vs Actual Longevity Outcomes

This distinction applies far beyond NAD+.

Longevity research frequently examines biomarkers such as:

• NAD+ concentrations
• Inflammatory markers
• Insulin sensitivity
• Mitochondrial activity
• Epigenetic-age measurements
• Lipid markers
• Glucose
• Biological-age scores

These can be useful research tools.

But changing a biomarker does not automatically prove that an intervention changes disease risk or lifespan.

For example:

If an intervention increases NAD+ by 50%, that tells us the intervention affected NAD metabolism.

It does not automatically tell us that the person will:

• Feel more energetic
• Lose weight
• Build more muscle
• Avoid dementia
• Prevent cardiovascular disease
• Live five years longer

Clinical outcomes require their own evidence.

Where NAD+ May Eventually Fit Into Longevity Medicine

The most reasonable future for NAD-related therapies may not be as universal “anti-aging” treatments.

Instead, researchers may identify specific populations who benefit most.

Possibilities could include people with particular:

• Metabolic abnormalities
• Age-related NAD+ deficiencies
• Mitochondrial dysfunction
• Cardiovascular risk profiles
• Neurological conditions
• Genetic differences affecting NAD metabolism

Researchers may also discover that specific compounds or routes work better for certain clinical situations.

We simply do not have enough evidence yet to make those distinctions confidently.

What Should Come Before NAD+ in a Longevity Strategy?

NAD+ is scientifically interesting.

But if the goal is improving healthspan, the strongest human evidence still supports much less glamorous interventions.

Priorities generally include:

• Not smoking
• Regular cardiovascular exercise
• Resistance training
• Maintaining adequate muscle mass
• Managing blood pressure
• Improving insulin sensitivity
• Managing cholesterol and cardiovascular risk
• Eating a nutrient-dense diet
• Getting adequate and consistent sleep
• Identifying and treating sleep apnea
• Limiting alcohol
• Maintaining social connection
• Receiving appropriate preventive screening

These interventions are supported by far more human outcome data than NAD+ therapy.

That does not mean emerging longevity tools should be ignored.

It means they should be placed on top of a strong foundation rather than used instead of one.

Who Should Consider NAD+ Testing or Therapy?

There is currently no universal guideline recommending routine NAD+ testing or supplementation for healthy adults.

Someone considering NAD-related therapy should first ask what problem they are trying to solve.

For example, persistent fatigue could also be associated with:

• Poor sleep
• Sleep apnea
• Iron deficiency
• Thyroid dysfunction
• Inadequate calorie intake
• Low protein intake
• Medication effects
• Depression or chronic stress
• Hormonal changes
• Insulin resistance
• Excessive training
• Other medical conditions

Jumping immediately to an NAD+ infusion may bypass the more important question:

Why is the symptom happening in the first place?

A thorough health evaluation can help determine whether there is a more established and treatable contributor.

The Bottom Line on NAD+ and Longevity

NAD+ is one of the most biologically compelling areas of modern longevity research.

But compelling biology and proven treatment are not the same thing.

Here is where the evidence currently stands:

Oral NR and NMN:
Human trials consistently show that these compounds can influence NAD+ metabolism. Some studies report promising effects on specific metabolic or physiological outcomes, but results are inconsistent and long-term longevity benefits remain unproven.

Injectable NAD+ or NAD+ precursors:
Research is emerging, but the human evidence base remains small. We do not yet have strong evidence showing injections improve healthspan or lifespan compared with oral supplementation.

IV NAD+:
Small studies demonstrate that IV administration affects NAD-related metabolism and provide early information about tolerability. However, there are no convincing randomized outcomes trials showing IV NAD+ reverses aging or extends human life.

NAD+ may eventually become an important component of precision longevity medicine.

For now, it should be viewed as an emerging intervention rather than a proven anti-aging therapy.

The more useful question is not:

“How high can I push my NAD+?”

It is:

“What intervention has the strongest evidence for improving the health outcome I actually care about?”

That approach keeps longevity medicine focused on measurable health rather than biomarkers alone.

Frequently Asked Questions About NAD+ and Longevity

Does NAD+ slow aging?

NAD+ plays an important role in cellular metabolism and age-related biology, but no human clinical trial has established that NAD+ supplementation slows the overall human aging process or extends lifespan.

Which is better, NMN or NR?

Both are NAD+ precursors and both can affect NAD metabolism. NR currently has a substantial body of human research, while NMN research has expanded rapidly. There is not enough evidence to say that one universally produces better longevity outcomes.

Is IV NAD+ better than oral NAD+ supplements?

There is currently no high-quality evidence showing that IV NAD+ provides superior longevity benefits compared with oral NAD+ precursors. IV delivery is more invasive and introduces additional cost, tolerability, sterility, and quality-control considerations.

Does NAD+ increase energy?

Because NAD+ participates in cellular energy metabolism, it is often marketed for energy. However, fatigue has many possible causes, and human trials have not established NAD+ therapy as a universal treatment for low energy.

How quickly does NAD+ work?

Changes in NAD-related biomarkers can occur relatively quickly depending on the compound and route. Whether someone experiences a meaningful improvement in symptoms is much less predictable.

Are NAD+ injections FDA approved?

Compounded NAD+ injections are not FDA-approved as anti-aging or longevity treatments. FDA has also raised concerns about quality and sterility issues involving some compounded injectable NAD+ products.

Can NAD+ make you live longer?

There is currently no human evidence demonstrating that NAD+, NR, or NMN supplementation increases lifespan.

Is NAD+ worth taking?

That depends on the goal, medical history, product, cost, and tolerance for uncertainty. NAD+ precursors are biologically active, but they should not be presented as replacements for interventions with established health span benefits.

References

1. Gallagher C, et al. NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews. 2026. 
2. Martens CR, et al. Clinical research evaluating nicotinamide riboside and NAD+ metabolism in adults.
3. Conze D, et al. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports. 2019.
4. Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021. 
5. Systematic review and meta-analysis of oral NMN supplementation in adults. 2026. 
6. Grant R, et al. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Frontiers in Aging Neuroscience. 2019. 
7. Reyna K, et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. 2026. 
8. U.S. Food and Drug Administration. FDA reminds compounders to use ingredients suitable for sterile compounding. 
9. U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. 
10. ClinicalTrials.gov. Current studies evaluating injectable nicotinamide riboside and NAD+. 

 

Medical Disclaimer: This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. NAD+ supplements, injections, and IV therapies may not be appropriate for everyone. Decisions about supplementation or medical therapy should be made with a qualified healthcare professional based on your medical history, medications, symptoms, and individual risk factors.